207 related articles for article (PubMed ID: 35733960)
1. Repurposing the Sphingosine-1-Phosphate Receptor Modulator Etrasimod as an Antibacterial Agent Against Gram-Positive Bacteria.
Zore M; Gilbert-Girard S; San-Martin-Galindo P; Reigada I; Hanski L; Savijoki K; Fallarero A; Yli-Kauhaluoma J; Patel JZ
Front Microbiol; 2022; 13():926170. PubMed ID: 35733960
[TBL] [Abstract][Full Text] [Related]
2. Design and synthesis of etrasimod derivatives as potent antibacterial agents against Gram-positive bacteria.
Zore M; San-Martin-Galindo P; Reigada I; Hanski L; Fallarero A; Yli-Kauhaluoma J; Patel JZ
Eur J Med Chem; 2024 Jan; 263():115921. PubMed ID: 37948883
[TBL] [Abstract][Full Text] [Related]
3. Screening of FDA-Approved Drugs Using a 384-Well Plate-Based Biofilm Platform: The Case of Fingolimod.
Gilbert-Girard S; Savijoki K; Yli-Kauhaluoma J; Fallarero A
Microorganisms; 2020 Nov; 8(11):. PubMed ID: 33233348
[TBL] [Abstract][Full Text] [Related]
4. Membrane-active amino acid-coupled polyetheramine derivatives with high selectivity and broad-spectrum antibacterial activity.
Li H; Li Y; Wang Y; Liu L; Dong H; Satoh T
Acta Biomater; 2022 Apr; 142():136-148. PubMed ID: 35158080
[TBL] [Abstract][Full Text] [Related]
5. Antibacterial and antivirulence factor activities of protein hydrolysates from Phatthalung Sangyod rice (
Rodjan P; Sangkanu S; Mitsuwan W; Pongpom M; Saengsawang P; Tedja I; Lamai J; Pruksaphon K; Jeenkeawpieam J
Vet World; 2023 Oct; 16(10):2002-2015. PubMed ID: 38023279
[TBL] [Abstract][Full Text] [Related]
6. Repurposing of the Tamoxifen Metabolites to Treat Methicillin-Resistant Staphylococcus epidermidis and Vancomycin-Resistant Enterococcus faecalis Infections.
Miró-Canturri A; Vila-Domínguez A; Caretero-Ledesma M; Ayerbe-Algaba R; Pachón J; Jiménez-Mejías ME; Smani Y
Microbiol Spectr; 2021 Oct; 9(2):e0040321. PubMed ID: 34668743
[TBL] [Abstract][Full Text] [Related]
7. Antibacterial naphthoquinone derivatives targeting resistant strain Gram-negative bacteria in biofilms.
Novais JS; Moreira CS; Silva ACJA; Loureiro RS; Sá Figueiredo AM; Ferreira VF; Castro HC; da Rocha DR
Microb Pathog; 2018 May; 118():105-114. PubMed ID: 29550501
[TBL] [Abstract][Full Text] [Related]
8. Antibacterial and anti-quorum sensing activities of a substituted thiazole derivative against methicillin-resistant Staphylococcus aureus and other multidrug-resistant bacteria.
Ibrahim YM; Abouwarda AM; Nasr T; Omar FA; Bondock S
Microb Pathog; 2020 Dec; 149():104500. PubMed ID: 32926996
[TBL] [Abstract][Full Text] [Related]
9. Antibacterial Properties of Tebipenem Pivoxil Tablet, a New Oral Carbapenem Preparation against a Variety of Pathogenic Bacteria in Vitro and in Vivo.
Yao Q; Wang J; Cui T; Yang Z; Su M; Zhao P; Yan H; Zhan Y; Yang H
Molecules; 2016 Jan; 21(1):62. PubMed ID: 26751436
[TBL] [Abstract][Full Text] [Related]
10. [Analysis of distribution and drug resistance of pathogens from the wounds of 1 310 thermal burn patients].
Zhang C; Gong YL; Luo XQ; Liu MX; Peng YZ
Zhonghua Shao Shang Za Zhi; 2018 Nov; 34(11):802-808. PubMed ID: 30481922
[No Abstract] [Full Text] [Related]
11. Cleistochlamys kirkii chemical constituents: Antibacterial activity and synergistic effects against resistant Staphylococcus aureus strains.
Pereira F; Madureira AM; Sancha S; Mulhovo S; Luo X; Duarte A; Ferreira MJ
J Ethnopharmacol; 2016 Feb; 178():180-7. PubMed ID: 26674158
[TBL] [Abstract][Full Text] [Related]
12. Searching for a potential antibacterial lead structure against bacterial biofilms among new naphthoquinone compounds.
Moreira CS; Silva AC; Novais JS; Sá Figueiredo AM; Ferreira VF; da Rocha DR; Castro HC
J Appl Microbiol; 2017 Mar; 122(3):651-662. PubMed ID: 27930849
[TBL] [Abstract][Full Text] [Related]
13. Coriander essential oil and linalool - interactions with antibiotics against Gram-positive and Gram-negative bacteria.
Aelenei P; Rimbu CM; Guguianu E; Dimitriu G; Aprotosoaie AC; Brebu M; Horhogea CE; Miron A
Lett Appl Microbiol; 2019 Feb; 68(2):156-164. PubMed ID: 30471142
[TBL] [Abstract][Full Text] [Related]
14. The Mechanism of Action of Ginkgolic Acid (15:1) against Gram-Positive Bacteria Involves Cross Talk with Iron Homeostasis.
Wen Z; Zhao Y; Gong Z; Tang Y; Xiong Y; Chen J; Chen C; Zhang Y; Liu S; Zheng J; Li D; Deng Q; Yu Z
Microbiol Spectr; 2022 Feb; 10(1):e0099121. PubMed ID: 35019708
[TBL] [Abstract][Full Text] [Related]
15. Drug repurposing: phosphate prodrugs of anticancer and antiviral FDA-approved nucleosides as novel antimicrobials.
Pertusati F; Pileggi E; Richards J; Wootton M; Van Leemputte T; Persoons L; De Coster D; Villanueva X; Daelemans D; Steenackers H; McGuigan C; Serpi M
J Antimicrob Chemother; 2020 Oct; 75(10):2864-2878. PubMed ID: 32688391
[TBL] [Abstract][Full Text] [Related]
16. Synergistic and Additive Effect of Oregano Essential Oil and Biological Silver Nanoparticles against Multidrug-Resistant Bacterial Strains.
Scandorieiro S; de Camargo LC; Lancheros CA; Yamada-Ogatta SF; Nakamura CV; de Oliveira AG; Andrade CG; Duran N; Nakazato G; Kobayashi RK
Front Microbiol; 2016; 7():760. PubMed ID: 27242772
[TBL] [Abstract][Full Text] [Related]
17. Etrasimod: A Sphingosine-1-Phosphate Receptor Modulator for the Treatment of Ulcerative Colitis.
Choi D; Becker M; Ivanov M; Bhat S
Ann Pharmacother; 2024 Jan; ():10600280231225770. PubMed ID: 38258760
[TBL] [Abstract][Full Text] [Related]
18. The antibacterial activity of extracts of nine plant species with good activity against Escherichia coli against five other bacteria and cytotoxicity of extracts.
Elisha IL; Botha FS; McGaw LJ; Eloff JN
BMC Complement Altern Med; 2017 Feb; 17(1):133. PubMed ID: 28241818
[TBL] [Abstract][Full Text] [Related]
19. A novel bis(pyrazolyl)methane compound as a potential agent against Gram-positive bacteria.
Seguí P; Aguilera-Correa JJ; Domínguez-Jurado E; Sánchez-López CM; Pérez-Tanoira R; Ocaña AV; Castro-Osma JA; Esteban J; Marcilla A; Alonso-Moreno C; Pérez-Martínez FC; Molina-Alarcón M
Sci Rep; 2021 Aug; 11(1):16306. PubMed ID: 34381091
[TBL] [Abstract][Full Text] [Related]
20. Etrasimod for the treatment of ulcerative colitis.
Wils P; Peyrin-Biroulet L
Immunotherapy; 2023 Apr; 15(5):311-321. PubMed ID: 36789612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
